Perspectives for the Use of Bispecific Antibodies in the Third- and Subsequent-Line Therapies of Follicular Lymphoma (Resolution of Expert Panel). Клиническая онкогематология [Internet]. 2023 Mar. 3 [cited 2026 Jan. 13];16(2):227-8. Available from: https://bloodjournal.ru/index.php/coh/article/view/29